We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Low‐dose rituximab plus high‐dose dexamethasone in newly diagnosed immune thrombocytopenia.
- Authors
Coronado‐Alejandro, Edgar Ulises; Martínez‐Hernández, Juan Pablo; Gómez‐De León, Andrés; Colunga‐Pedraza, Perla Rocío; Jaime‐Pérez, José Carlos; Cantú‐Rodríguez, Olga Graciela; Gutiérrez‐Aguirre, César Homero; Gómez‐Almaguer, David
- Abstract
1 TABLE Characteristics of 17 newly diagnosed patients with immune thrombocytopenic purpura treated with low-dose rituximab and high-dose dexamethasone. Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
- Subjects
RITUXIMAB; DEXAMETHASONE; RESOURCE-limited settings
- Publication
European Journal of Haematology, 2023, Vol 110, Issue 6, p778
- ISSN
0902-4441
- Publication type
Correction Notice
- DOI
10.1111/ejh.13954